Side effects of quinolones;Struktur-wirkungs-beziehungen und nebenwirkungen von chinolon-derivaten

Krankenhauspharmazie

Volumn 22, Issue 8, 2001, Pages 359-366

  Strehl, E ^a   Hofmann, C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cardiotoxicity; Central nervous disorders; Phototoxicity; Quinolones; Structure related adverse events

Indexed keywords

ACETYLSALICYLIC ACID; AJMALINE; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; CALCIUM ANTAGONIST; CIPROFLOXACIN; CYCLOSPORIN; DISOPYRAMIDE; ENOXACIN; FLEROXACIN; GATIFLOXACIN; GEMIFLOXACIN; GLIBENCLAMIDE; IBUPROFEN; KETOPROFEN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; NORFLOXACIN; OFLOXACIN; PROCAINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SOTALOL; SPARFLOXACIN; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; WARFARIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DRUG INDUCED DISEASE; DRUG SAFETY; GASTROINTESTINAL TOXICITY; HUMAN; LIVER TOXICITY; MAJOR CLINICAL STUDY; MUSCULOSKELETAL SYSTEM; NEUROTOXICITY; PHOTOTOXICITY; REVIEW; SIDE EFFECT;

EID: 0034876539     PISSN: 01737597     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Pharmacocinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers
2. Tolerability of fluoroquinolone antibiotics. Past, present and future
3. Quinolone-induced QT interval prolongation: A not so unexpected class effect
4. Classification and structure-activity relationships of fluoroquinolones
5. Safety of the fluoroquinolone antibiotics: Focus on molecular structure
6. Effects of some excitatory amino acid antagonists and drugs enhancing γ-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice
7. Effect of quinolones on intestinal ecology
8. Phototoxic potential of gatifloxacin, a new fluoroquinolone antimicrobial
9. The withdrawal of temafloxacin: Are there implications for other quinolones?
10. Fluoroquinolone-induced tendinopathy: Also occurring with levofloxacin
11. Efficacy and safety of moxifloxacin vs. clarithromycin for community acquired pneumonia
12. Inhibitory potency of quinolone antibacterial agent against cytochrom P 450 1A2 activity in vivo and in vitro
13. Fluoroquinolones in paediatrics
14. Levofloxacin - A review: Its use in infections of the respiratory tract, skin, soft tissue and urinary tract
15. Fluoroquinolone toxicities: An update
16. Gemifloxacin
17. Fluoroquinolone phototoxicity: A comparison of moxifloxacin and lomefloxacin in normal volunteers
18. Gatifloxacin
19. Levofloxacin versus cefuroxime axetil in the treatment of chronic bronchitis: Results of a randomized, double-blind study
20. Nebenwirkungen der neuen fluorochinolone
21. Safety overview, toxicity, adverse effects and drug interactions
22. Toxicity of quinolones
23. Safety profile of grepafloxacin as compared with other fluoroquinolones
24. Pharmacokinetics of moxifloxacin in special populations
25. Quinolone antibacterials: An update of their pharmacology
26. Five day moxifloxacin therapy compared with seven day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis